Association between the C-reactive protein-triglyceride-glucose index and major adverse cardiovascular events in patients undergoing percutaneous coronary intervention - Scorecard - MDSpire
Advertisement
Association between the C-reactive protein-triglyceride-glucose index and major adverse cardiovascular events in patients undergoing percutaneous coronary intervention
Clinical Scorecard: Link Between the C-Reactive Protein-Triglyceride-Glucose Index and Major Adverse Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention
At a Glance
Category
Detail
Condition
Key Mechanisms
Target Population
Patients aged 18 to 80 years with CAD undergoing PCI, excluding those with acute infections or recent surgeries.
Care Setting
Key Highlights
CTI (C-reactive protein-triglyceride-glucose index) is an independent predictor of MACEs following PCI.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Monitor CTI levels at 1 month, 3 months, and 6 months post-PCI to predict and manage cardiovascular risk.
Risks
Patient & Prescribing Data
Patients aged 18 to 80 years with CAD undergoing PCI.
CTI combines CRP and TyG index to assess inflammation and insulin resistance.
Clinical Best Practices
Incorporate CTI assessment in pre-PCI evaluations, supported by recent studies.
